Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma
Phase III randomised-controlled trial for patients with unilateral malignant pleural mesothelioma (MPM).
Trial Details
- NCT ID
- NCT05655078
- Phase
- NA
- Sponsor
- University College, London
- Status
- RECRUITING
- Cancer Type
- Lung Cancer
- Interventions
- Locations (sample)
- Eastbourne, East Sussex, United Kingdom|50.76871,0.28453
- Saint Leonards-on-Sea, East Sussex, United Kingdom|50.85565,0.5452
- Reading, England, United Kingdom|51.45625,-0.97113
- Southend, Essex, United Kingdom|55.31667,-5.63333
- Portsmouth, Hampshire, United Kingdom|50.79899,-1.09125
Key Eligibility Criteria
- Patients ≥18 years of age, with biopsy confirmed MPM and histological subtyping (epithelioid or non-epithelioid)
- N0 or N1 and M0 disease
- Written informed consent
- Patient and local/regional MDT opt for active surveillance and deferral of SACT until clinical or radiological progression
For full eligibility, visit ClinicalTrials.gov.
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Lung Cancer Trials on Trialify →